Ligand · 0DO
0DO · (2R,4S)-N-tert-butyl-1-[(2S,3S)-3-{[(2,6-dimethylphenoxy)acetyl]amino}-2-hydroxy-4-phenylbutyl]-4-(pyridin-4-ylsulfonyl)piperidine-2-carboxamide
0DO, (2R,4S)-N-tert-butyl-1-[(2S,3S)-3-{[(2,6-dimethylphenoxy)acetyl]amino}-2-hydroxy-4-phenylbutyl]-4-(pyridin-4-ylsulfonyl)piperidine-2-carboxamide (C35 H46 N4 O6 S, 650.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records…
- Component
- 0DO
- Formula
- C35 H46 N4 O6 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
0DO in 2 structures; the first of them:
- 1IDB · Crystal structures of HIV-2 protease in complex with inhibitors containing the… · 0DO B100 · binds ASP25, GLY27, ALA28, ASP30, ILE32, VAL47, GLY48, GLY49 and 21 more
- 1IDB · Crystal structures of HIV-2 protease in complex with inhibitors containing the… · 0DO B100 · binds ASP25, GLY27, ALA28, ASP30, ILE32, VAL47, GLY48, GLY49 and 21 more
Residues it binds most
ILE 2, GLY 2, ASP 2, ALA 2, PRO 2, VAL 2, ARG 2, LEU 2, MET 2, THR 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.